丙泊酚联合富氢盐水对脓毒症小鼠器官损伤及细胞因子的影响
该研究将140只雄性C57BL/6小鼠随机分为假手术组、盲肠结扎穿孔(CLP)组、丙泊酚组、氢气(H2)组及丙泊酚联合H2组(每组n=28),CLP术后1小时和6小时经尾静脉给予丙泊酚50 mg/kg、腹腔给予富氢盐水5 mL/kg。每组20只观察7天生存率,每组8只于CLP后24小时采血及肺、肝、肾组织检测TNF-α、IL-1β、HMGB1及组织病理评分。结果显示CLP组1、2、3、5、7天生存率分别为80%、40%、20%、10%、0%,联合治疗组提高至90%、75%、60%、55%、55%;联合组各时间点生存率及炎症因子、组织学评分均优于丙泊酚组或H2组单药(均P<0.05)。作者认为两药联合应用效果更好。
要点
- CLP脓毒症小鼠7天生存率由0%提高至联合治疗组55%(联合组7天生存率55% vs 丙泊酚组40% vs H2组40%)。
- 联合组3天生存率60%,高于丙泊酚组50%和H2组50%;5天生存率55%,高于丙泊酚组45%和H2组40%。
- 联合组血TNF-α 367±74 ng/L,低于丙泊酚组612±132 ng/L和H2组588±117 ng/L(P<0.05)。
- 联合组肺、肝、肾组织学评分分别为1.22±0.28、1.38±0.32、1.19±0.25,均低于两个单药组(P<0.05)。
- 该结果为小鼠CLP模型实验数据,给药方案为丙泊酚50 mg/kg尾静脉、富氢盐水5 mL/kg腹腔注射,于CLP后1小时和6小时各一次。
适用人群与场景
- 雄性C57BL/6小鼠,采用盲肠结扎穿孔(CLP)法制备脓毒症模型;假手术组仅行相同手术操作并结扎穿刺。
处置流程与药物剂量
- 丙泊酚组及联合组于CLP后1小时和6小时经尾静脉给予丙泊酚50 mg/kg。
- H2组及联合组于CLP后1小时和6小时腹腔注射富氢盐水5 mL/kg。
研究设计与关键结果
- 研究类型为动物实验,140只雄性C57BL/6小鼠随机分为假手术组、CLP组、丙泊酚组、H2组及联合组,每组n=28;每组20只观察7天生存率,每组8只于CLP后24小时检测指标。
- CLP组1、2、3、5、7天生存率分别为80%、40%、20%、10%、0%;联合组分别为90%、75%、60%、55%、55%。
- 2、3、5、7天生存率:联合组75% vs 丙泊酚组60% vs H2组65%;联合组60% vs 丙泊酚组50% vs H2组50%;联合组55% vs 丙泊酚组45% vs H2组40%;联合组55% vs 丙泊酚组40% vs H2组40%。
- 血TNF-α(ng/L):联合组367±74 vs 丙泊酚组612±132 vs H2组588±117;血IL-1β(ng/L):联合组321±68 vs 丙泊酚组502±95 vs H2组476±86;血HMGB1(μg/L):联合组4.6±0.9 vs 丙泊酚组7.0±1.4 vs H2组6.8±1.3。
- 肺TNF-α(ng/g):联合组307±70 vs 丙泊酚组512±132 vs H2组488±102;肺IL-1β(ng/g):联合组367±77 vs 丙泊酚组571±108 vs H2组466±89;肺HMGB1(μg/g):联合组5.1±1.0 vs 丙泊酚组7.8±1.7 vs H2组7.1±1.5。
- 肝TNF-α(ng/g):联合组247±57 vs 丙泊酚组431±112 vs H2组389±87;肝IL-1β(ng/g):联合组267±58 vs 丙泊酚组417±85 vs H2组399±76;肝HMGB1(μg/g):联合组4.2±1.1 vs 丙泊酚组7.1±1.6 vs H2组6.6±1.2。
- 肾TNF-α(ng/g):联合组257±41 vs 丙泊酚组480±89 vs H2组448±82;肾IL-1β(ng/g):联合组258±39 vs 丙泊酚组409±68 vs H2组411±66;肾HMGB1(μg/g):联合组3.9±0.7 vs 丙泊酚组6.8±1.2 vs H2组5.7±1.0。
- 组织学评分:肺联合组1.22±0.28 vs 丙泊酚组2.61±0.49 vs H2组2.58±0.44;肝联合组1.38±0.32 vs 丙泊酚组2.76±0.51 vs H2组2.62±0.46;肾联合组1.19±0.25 vs 丙泊酚组2.43±0.41 vs H2组2.36±0.40;均P<0.05。
证据类型、等级与局限
- 证据类型:动物实验(小鼠CLP脓毒症模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该研究为小鼠CLP模型实验,作者认为丙泊酚与H2联合应用在提高生存率、减轻组织损伤和降低细胞因子释放方面优于单药,上述结果尚不能直接转化为临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the effect of combining propofol with hydrogen on organ damage and inflammation of sepsis in cecal ligation and puncture (CLP) mice model.
METHODS: One hundred and forty male C57BL/6 mice were randomly divided into groups (n = 28): sham group, CLP group, propofol group, H2 group, and propofol and H2 group. The sepsis was induced by CLP operation. Mice in sham group did the same operation with ligation and puncture. The mice of propofol group and propofol and H2 group were given 50 mg/kg propofol through tail vein at 1 hour and 6 hours after CLP and the mice of H2 group and propofol and H2 group were given 5 mL/kg H2-rich saline i.p. at 1 hour and 6 hours after CLP. The survival rates were observed during 7 days in twenty mice of each group. Inferior vena cava blood and part lung, liver and kidney tissue were collected for detection of the concentration of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and high mobility group box 1 (HMGB1) at 24 hours after CLP in the 40 animals left (each n = 8). Then, the rest tissue of lung, liver and kidney tissue were harvested to test histopathology and histological score.
RESULTS: The 1, 2, 3, 5, 7 days survival rate of septic mice were 80%, 40%, 20%, 10%, and 0%, respectively. The survival rate of animals increased significantly after propofol or hydrogen-rich treatment, and the combined treatment can further increase survival rate to 90%, 75%, 60%, 55%, and 55%, respectively. Compared with the sham group, inflammatory factors were significantly increased in blood and organ tissues, cell degeneration, necrosis, congestion and inflammatory cell infiltration in lung, liver and kidney, and tissues histological scores were significantly increased. The levels of inflammatory factors were reduced in blood and tissues, cell degeneration, necrosis, congestion and inflammatory cell infiltration were alleviated in lung, liver and kidney, and tissues histological scores were decreased after propofol or hydrogen-rich treatment compared with CLP group; these indicators were further improved in propofol and H2 group compared with propofol group or H2 group [2, 3, 5, 7-day survival rate: 75% vs. 60%, 65%; 60% vs. 50%, 50%; 55% vs. 45%, 40%; 55% vs. 40%, 40%; blood TNF-α (ng/L): 367±74 vs. 612±132, 588±117; blood IL-1β (ng/L): 321±68 vs. 502±95, 476±86; blood HMGB1 (μg/L): 4.6±0.9 vs. 7.0±1.4, 6.8±1.3; lung TNF-α (ng/g): 307±70 vs. 512±132, 488±102; lung IL-1β (ng/g): 367±77 vs. 571±108, 466±89; lung HMGB1 (μg/g): 5.1±1.0 vs. 7.8±1.7, 7.1±1.5; liver TNF-α (ng/g): 247±57 vs. 431±112, 389±87; liver IL-1β (ng/g): 267±58 vs. 417±85, 399±76; liver HMGB1 (μg/g): 4.2±1.1 vs. 7.1±1.6, 6.6±1.2; kidney TNF-α (ng/g): 257±41 vs. 480±89, 448±82; kidney IL-1β (ng/g): 258±39 vs. 409±68, 411±66; kidney HMGB1 (μg/g): 3.9±0.7 vs. 6.8±1.2, 5.7±1.0; histological scores: lung: 1.22±0.28 vs. 2.61±0.49, 2.58±0.44; liver: 1.38±0.32 vs. 2.76±0.51, 2.62±0.46; kidney: 1.19±0.25 vs. 2.43±0.41, 2.36±0.40; all P < 0.05].
CONCLUSIONS: Both propofol and H2 can improve the survival rate of sepsis, reduce tissue damage and the release of cytokines, and combined application of the two treatment was better.
参考来源
- Hong Y, Chen H, Yu Y, et al. [Effect of combination therapy with propofol and hydrogen-rich saline on organ damage and cytokines in a murine model of sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 28420464. doi:10.3760/cma.j.issn.2095-4352.2017.04.006
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。